{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:55:01Z","timestamp":1792644901131,"version":"4.5.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["5\\u00A0M-2022-23685490"],"award-info":[{"award-number":["5\\u00A0M-2022-23685490"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["5\\u00A0M-2017-23684161"],"award-info":[{"award-number":["5\\u00A0M-2017-23684161"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["2042"],"award-info":[{"award-number":["2042"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.humimm.2026.111702","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T23:39:07Z","timestamp":1771457947000},"page":"111702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The immunosuppressive role of HLA-G+ extracellular vesicles in bone marrow of infiltrating tumors: the lesson learned from neuroblastoma and multiple myeloma"],"prefix":"10.1016","volume":"87","author":[{"given":"Irma","family":"Airoldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5156-498X","authenticated-orcid":false,"given":"Debora","family":"Soncini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Marimpietri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Cea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2849-7595","authenticated-orcid":false,"given":"Fabio","family":"Morandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2026.111702_b0005","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1007\/s00018-011-0689-3","article-title":"Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles","volume":"68","author":"Gy\u00f6rgy","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.humimm.2026.111702_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207568","article-title":"Tetraspanins, more than Markers of Extracellular Vesicles in Reproduction","volume":"21","author":"Jankovi\u010dov\u00e1","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2026.111702_b0015","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.tcb.2023.01.002","article-title":"Extracellular vesicles and nanoparticles: emerging complexities","volume":"33","author":"Jeppesen","year":"2023","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.humimm.2026.111702_b0020","article-title":"Extracellular Vesicles: New Classification and Tumor Immunosuppression","volume":"12","author":"Sheta","year":"2023","journal-title":"Biology (basel)"},{"key":"10.1016\/j.humimm.2026.111702_b0025","article-title":"Tumor-derived extracellular vesicles modulate innate immune responses to affect tumor progression","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111702_b0030","article-title":"Landscape of tumor and immune system cells-derived exosomes in lung cancer: mediators of antitumor immunity regulation","volume":"14\u20132023","author":"Castillo-Pe\u00f1a","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111702_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119590","article-title":"Metastatic Dissemination: Role of Tumor-Derived Extracellular Vesicles and their use as Clinical Biomarkers","volume":"24","author":"Giusti","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2026.111702_b0040","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.3390\/biomedicines11092534","article-title":"Communicator Extraordinaire: Extracellular Vesicles in the Tumor Microenvironment are Essential local and Long-Distance Mediators of Cancer Metastasis","volume":"11","author":"Mitchell","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.humimm.2026.111702_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1385875","article-title":"Extracellular vesicles in neuroblastoma: role in progression, resistance to therapy and diagnostics","volume":"15","author":"Dhamdhere","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111702_b0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12967-025-07445-8","article-title":"Extracellular vesicles in multiple myeloma-bone marrow niche crosstalk: from cellular dialogue to clinical perspectives","volume":"24","author":"Forestiero","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.humimm.2026.111702_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020449","article-title":"Extracellular Vesicle microRNAs Contribute to the Osteogenic Inhibition of Mesenchymal Stem Cells in Multiple Myeloma","volume":"12","author":"Raimondo","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humimm.2026.111702_b0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/ncrna6030030","article-title":"Emerging Insights on the Biological Impact of Extracellular Vesicle-Associated ncRNAs in Multiple Myeloma","volume":"6","author":"Raimondo","year":"2020","journal-title":"Non-Coding RNA"},{"key":"10.1016\/j.humimm.2026.111702_b0065","article-title":"Dysregulation of the Bone Marrow Microenvironment in Pediatric Tumors: the Role of Extracellular Vesicles in Acute Leukemias and neuroblastoma","volume":"26","author":"D'Amico","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2026.111702_b0070","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41590-021-00899-0","article-title":"Extracellular vesicles in immunomodulation and tumor progression","volume":"22","author":"Marar","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2026.111702_b0075","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.4049\/jimmunol.180.11.7249","article-title":"Human tumor-derived exosomes down-modulate NKG2D expression","volume":"180","author":"Clayton","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2026.111702_b0080","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1002\/ijc.24249","article-title":"Induction of myeloid-derived suppressor cells by tumor exosomes","volume":"124","author":"Xiang","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.humimm.2026.111702_b0085","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.4049\/jimmunol.0900970","article-title":"Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes","volume":"183","author":"Wieckowski","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2026.111702_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1469771","article-title":"Immunomodulatory properties of extracellular vesicles isolated from bone marrow of patients with neuroblastoma: role of PD-L1 and HLA-G","volume":"15","author":"Marimpietri","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111702_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1640168","article-title":"Bone marrow-derived extracellular vesicles from multiple myeloma patients promote adaptive immune dysfunction via HLA-G, PD-1, and PD-L1","volume":"16","author":"Soncini","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111702_b0100","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1080\/07357907.2025.2529878","article-title":"Immunomodulation of the Breast Cancer Microenvironment by Tumor-Derived Exosomes: Implications for Immunotherapy","volume":"43","author":"Maralbashi","year":"2025","journal-title":"Cancer Invest."},{"key":"10.1016\/j.humimm.2026.111702_b0105","article-title":"Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD","volume":"7","author":"Morandi","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.humimm.2026.111702_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/cells9092123","article-title":"Human Amnion Epithelial Cells Impair T Cell Proliferation: the Role of HLA-G and HLA-E Molecules","volume":"9","author":"Morandi","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.humimm.2026.111702_b0115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.semcancer.2007.07.004","article-title":"Soluble HLA-G: are they clinically relevant?","volume":"17","author":"Pistoia","year":"2007","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.humimm.2026.111702_b0120","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.4049\/jimmunol.1900562","article-title":"Structural and Functional Basis for LILRB Immune Checkpoint Receptor Recognition of HLA-G Isoforms","volume":"203","author":"Kuroki","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2026.111702_b0125","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.febslet.2015.06.037","article-title":"ILT4 drives B7-H3 expression via PI3K\/AKT\/mTOR signalling and ILT4\/B7-H3 co-expression correlates with poor prognosis in non-small cell lung cancer","volume":"589","author":"Zhang","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.humimm.2026.111702_b0130","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1084\/jem.189.7.1093","article-title":"A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells","volume":"189","author":"Rajagopalan","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2026.111702_b0135","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fimmu.2012.00258","article-title":"KIR2DL4 (CD158d): an activation receptor for HLA-G","volume":"3","author":"Rajagopalan","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111702_b0140","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/359748","article-title":"The dual role of HLA-G in cancer","volume":"2014","author":"Rouas-Freiss","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.humimm.2026.111702_b0145","doi-asserted-by":"crossref","first-page":"17957","DOI":"10.1073\/pnas.1221535110","article-title":"Exocytosis acts as a modulator of the ILT4-mediated inhibition of neutrophil functions","volume":"110","author":"Baudhuin","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.humimm.2026.111702_b0150","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1182\/blood-2009-07-234872","article-title":"Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4\/HLA-G pathway","volume":"116","author":"Gregori","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2026.111702_b0155","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/eji.201646564","article-title":"HLA-G promotes myeloid-derived suppressor cell accumulation and suppressive activity during human pregnancy through engagement of the receptor ILT4","volume":"47","author":"K\u00f6stlin","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2026.111702_b0160","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1084\/jem.20030305","article-title":"Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential","volume":"198","author":"Koopman","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2026.111702_b0165","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/sj.cr.7290283","article-title":"Residues Met76 and Gln79 in HLA-G alpha1 domain involve in KIR2DL4 recognition","volume":"15","author":"Yan","year":"2005","journal-title":"Cell Res."},{"key":"10.1016\/j.humimm.2026.111702_b0170","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1158\/1078-0432.CCR-05-0456","article-title":"Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"11","author":"Leleu","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.humimm.2026.111702_b0175","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2141.2007.06647.x","article-title":"Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders","volume":"138","author":"Sebti","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.humimm.2026.111702_b0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23062925","article-title":"HLA-G and Other Immune Checkpoint Molecules as Targets for Novel combined Immunotherapies","volume":"23","author":"Morandi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2026.111702_b0185","doi-asserted-by":"crossref","first-page":"782","DOI":"10.2119\/molmed.2015.00083","article-title":"Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy","volume":"21","author":"Lin","year":"2015","journal-title":"Mol. Med."},{"key":"10.1016\/j.humimm.2026.111702_b0190","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2011.07.019","article-title":"Human leukocyte antigen-G in cancer: are they clinically relevant?","volume":"311","author":"Yan","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.humimm.2026.111702_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1165813","article-title":"Prognostic value of human leukocyte antigen G expression in solid tumors: a systematic review and meta-analysis","volume":"14","author":"Bartolome","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111702_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.811200","article-title":"The Human Leukocyte Antigen G as an Immune Escape Mechanism and Novel Therapeutic Target in Urological Tumors","volume":"13","author":"Jasinski-Bergner","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111702_b0205","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju257","article-title":"The role of microRNAs in the control of innate immune response in cancer","volume":"106","author":"Jasinski-Bergner","year":"2014","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.humimm.2026.111702_b0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213686","article-title":"Detection of Measurable Residual Disease Biomarkers in Extracellular Vesicles from Liquid Biopsies of Multiple Myeloma Patients-a Proof of Concept","volume":"23","author":"Bergantim","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2026.111702_b0215","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.3324\/haematol.2021.279716","article-title":"Extracellular vesicles mediate the communication between multiple myeloma and bone marrow microenvironment in a NOTCH dependent way","volume":"107","author":"Giannandrea","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.humimm.2026.111702_b0220","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1574198","article-title":"Microvesicles expressing adenosinergic ectoenzymes and their potential role in modulating bone marrow infiltration by neuroblastoma cells","volume":"8","author":"Morandi","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.humimm.2026.111702_b0225","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2017.1332941","article-title":"Contribution of neuroblastoma-derived exosomes to the production of pro-tumorigenic signals by bone marrow mesenchymal stromal cells","volume":"6","author":"Nakata","year":"2017","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.humimm.2026.111702_b0230","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2020.1774144","article-title":"Neuroblastoma-secreted exosomes carrying miR-375 promote osteogenic differentiation of bone-marrow mesenchymal stromal cells","volume":"9","author":"Colletti","year":"2020","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.humimm.2026.111702_b0235","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.1158\/1078-0432.CCR-12-3697","article-title":"Molecular pathways: human leukocyte antigen G (HLA-G)","volume":"19","author":"Curigliano","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.humimm.2026.111702_b0240","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.humimm.2016.01.002","article-title":"The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients","volume":"77","author":"K\u00f6nig","year":"2016","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2026.111702_b0245","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.humimm.2003.08.344","article-title":"Exosomes bearing HLA-G are released by melanoma cells","volume":"64","author":"Riteau","year":"2003","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2026.111702_b0250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1670611","article-title":"Soluble HLA-G is related to malignant melanocytic lesions and previous oncological disease may increase circulating HLA-G bearing large extracellular vesicles","volume":"16","author":"Silva-Krebs","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111702_b0255","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081106","article-title":"Vesicular-Bound HLA-G as a Predictive Marker for Disease Progression in Epithelial Ovarian Cancer","volume":"11","author":"Schwich","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humimm.2026.111702_b0260","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1186\/s12885-015-2025-z","article-title":"Role of HLA-G and extracellular vesicles in renal cancer stem cell-induced inhibition of dendritic cell differentiation","volume":"15","author":"Grange","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.humimm.2026.111702_b0265","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.3389\/fimmu.2020.02046","article-title":"Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 positive and ILT-2 negative CD8 T Cells Complementary","volume":"11","author":"Schwich","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111702_b0270","article-title":"HLA-G\/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: potential Role as Biomarkers","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111702_b0275","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1111\/febs.70093","article-title":"Extracellular vesicles in multiple myeloma: pathogenesis and therapeutic application","volume":"292","author":"Wylie","year":"2025","journal-title":"FEBS J."},{"key":"10.1016\/j.humimm.2026.111702_b0280","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/aji.12507","article-title":"High Amounts of Total and Extracellular Vesicle-Derived Soluble HLA-G are Associated with HLA-G 14-bp Deletion Variant in Women with embryo Implantation failure","volume":"75","author":"Nardi Fda","year":"2016","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2026.111702_b0285","doi-asserted-by":"crossref","first-page":"13119","DOI":"10.1038\/s41598-023-40132-6","article-title":"Soluble HLA-G (sHLA-G) measurement might be useful as an early diagnostic biomarker and screening test for gastric cancer","volume":"13","author":"Mej\u00eda-Guarnizo","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.humimm.2026.111702_b0290","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12967-024-04938-w","article-title":"Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects","volume":"22","author":"Wang","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.humimm.2026.111702_b0295","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMra0804577","article-title":"Recent advances in neuroblastoma","volume":"362","author":"Maris","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2026.111702_b0300","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrc3526","article-title":"Neuroblastoma: developmental biology, cancer genomics and immunotherapy","volume":"13","author":"Cheung","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.humimm.2026.111702_b0305","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","article-title":"The International neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report","volume":"27","author":"Cohn","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.humimm.2026.111702_b0310","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/nyas.12554","article-title":"Evaluation of bone marrow as a metastatic site of human neuroblastoma","volume":"1335","author":"Morandi","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.humimm.2026.111702_b0315","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/leu.2014.70","article-title":"Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma","volume":"28","author":"Affer","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.humimm.2026.111702_b0320","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115674","article-title":"Immunotherapy of Multiple Myeloma: Current Status as Prologue to the Future","volume":"24","author":"Abramson","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2026.111702_b0325","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.3390\/curroncol30020179","article-title":"Relapsed\/Refractory Multiple Myeloma: a Review of Available Therapies and Clinical Scenarios Encountered in Myeloma Relapse","volume":"30","author":"Bhatt","year":"2023","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.humimm.2026.111702_b0330","doi-asserted-by":"crossref","first-page":"6433","DOI":"10.1158\/0008-5472.CAN-06-4588","article-title":"Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release","volume":"67","author":"Morandi","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.humimm.2026.111702_b0335","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7465741","article-title":"Soluble HLA-G and HLA-E Levels in Bone Marrow Plasma Samples are Related to Disease Stage in neuroblastoma patients","volume":"2016","author":"Morandi","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.humimm.2026.111702_b0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029922","article-title":"Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins","volume":"7","author":"Morandi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2026.111702_b0345","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1044-579X(03)00029-4","article-title":"HLA-G and lymphoproliferative disorders","volume":"13","author":"Amiot","year":"2003","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.humimm.2026.111702_b0350","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood-2012-03-416792","article-title":"CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis","volume":"120","author":"Brown","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2026.111702_b0355","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/leu.2008.15","article-title":"NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G","volume":"22","author":"Maki","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.humimm.2026.111702_b0360","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1279495","article-title":"Landscape of tumor and immune system cells-derived exosomes in lung cancer: mediators of antitumor immunity regulation","volume":"14","author":"Castillo-Pe\u00f1a","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111702_b0365","doi-asserted-by":"crossref","unstructured":"Mitchell MI, Loudig O: Communicator Extraordinaire: Extracellular Vesicles in the Tumor Microenvironment Are Essential Local and Long-Distance Mediators of Cancer Metastasis. Biomedicines 2023;11.","DOI":"10.3390\/biomedicines11092534"},{"key":"10.1016\/j.humimm.2026.111702_b0370","doi-asserted-by":"crossref","DOI":"10.3390\/cells12212516","article-title":"Plasma-Derived Exosome Proteins as Novel Diagnostic and Prognostic Biomarkers in neuroblastoma patients","volume":"12","author":"Morini","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.humimm.2026.111702_b0375","article-title":"Recent advances in the roles of exosomal microRNAs in neuroblastoma","volume":"12","author":"Bhavsar","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.humimm.2026.111702_b0380","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1158\/0008-5472.CAN-19-0021","article-title":"Exosomal miRNA Cargo as Mediator of Immune Escape Mechanisms in neuroblastoma","volume":"79","author":"Schmittgen","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.humimm.2026.111702_b0385","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-3-030-50224-9_5","article-title":"Exosomes: Novel Players of Therapy Resistance in neuroblastoma","volume":"1277","author":"Richard","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.humimm.2026.111702_b0390","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004399","article-title":"Small extracellular vesicles induce resistance to anti-GD2 immunotherapy unveiling tipifarnib as an adjunct to neuroblastoma immunotherapy","volume":"10","author":"Liu","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.humimm.2026.111702_b0395","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22083964","article-title":"The Role of Extracellular Vesicles in the Progression of Human neuroblastoma","volume":"22","author":"Marimpietri","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2026.111702_b0400","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1265969","article-title":"Extracellular vesicles in hematological malignancies: EV-dence for reshaping the tumoral microenvironment","volume":"14","author":"Van Morckhoven","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111702_b0405","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1182\/blood.2021014749","article-title":"Exosomes in multiple myeloma: from bench tobedside","volume":"140","author":"Menu","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2026.111702_b0410","doi-asserted-by":"crossref","DOI":"10.3390\/cells10113185","article-title":"Role of Extracellular Vesicle-based Cell-to-Cell Communication in Multiple Myeloma Progression","volume":"10","author":"Saltarella","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.humimm.2026.111702_b0415","series-title":"Basile a","first-page":"20","author":"Colombo","year":"2019"},{"key":"10.1016\/j.humimm.2026.111702_b0420","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2147\/JIR.S347777","article-title":"Tumor-Infiltrating PD-L1+ Neutrophils Induced by GM-CSF Suppress T Cell Function in Laryngeal Squamous Cell Carcinoma and Predict Unfavorable Prognosis","volume":"15","author":"Tang","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.humimm.2026.111702_b0425","first-page":"589","article-title":"Oral squamous cell carcinoma cell-derived GM-CSF regulates PD-L1 expression in tumor-associated macrophages through the JAK2\/STAT3 signaling pathway","volume":"13","author":"Wang","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.humimm.2026.111702_b0430","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0268-960X(97)90019-9","article-title":"Role of alpha interferon in multiple myeloma","volume":"11","author":"Joshua","year":"1997","journal-title":"Blood Rev."},{"key":"10.1016\/j.humimm.2026.111702_b0435","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.canlet.2004.11.063","article-title":"Interferon-mediated anti-angiogenic therapy for neuroblastoma","volume":"228","author":"Streck","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.humimm.2026.111702_b0440","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.smim.2014.01.008","article-title":"The two faces of IL-6 in the tumor microenvironment","volume":"26","author":"Fisher","year":"2014","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.humimm.2026.111702_b0445","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1182\/blood.V78.8.2070.2070","article-title":"Interleukin-4 Inhibits growth of Multiple Myelomas by Suppressing Interleukin-6 Expression","volume":"78","author":"Herrmann","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2026.111702_b0450","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s12253-015-9921-z","article-title":"Interleukin-10 Induces both Plasma Cell Proliferation and Angiogenesis in Multiple Myeloma","volume":"21","author":"Alexandrakis","year":"2015","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.humimm.2026.111702_b0455","first-page":"65","article-title":"Tumor necrosis factor is a survival and proliferation factor for human myeloma cells","volume":"10","author":"Jourdan","year":"1999","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.humimm.2026.111702_b0460","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202516348","article-title":"PD-L1 on Tumor-Derived Extracellular Vesicles Induces CD8+ T Cell Terminal Exhaustion and Mediates Anti-PD-1 Resistance in Head and Neck Squamous Cell Carcinoma","volume":"13","author":"Fang","year":"2026","journal-title":"Adv. Sci."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926000480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926000480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:28:07Z","timestamp":1781857687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885926000480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":92,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0198885926000480"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2026.111702","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immunosuppressive role of HLA-G+ extracellular vesicles in bone marrow of infiltrating tumors: the lesson learned from neuroblastoma and multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2026.111702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111702"}}